Cell-type, dose, and mutation-type specificity dictate mutant p53 functions in vivo

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The roles of mutant p53's dominant-negative (DN) and gain-of-function (GOF) properties in cancer are not fully understood.
• Investigating these properties is crucial for understanding tumorigenesis and developing targeted therapies.

Purpose of the Study:

• To elucidate the specific roles of mutant p53's DN and GOF properties in acute responses and long-term tumorigenesis.
• To differentiate the effects of the R246S mutant p53 in various cellular contexts and cancer models.

Main Methods:

• Utilized "knockin" mouse strains with varying levels of R246S mutant p53.
• Assessed the dominant-negative effect on transactivation and cellular outcomes.
• Evaluated the impact of mutant p53 on radiation-induced death and tumorigenesis in different models, including those with absent MDM2.

Main Results:

• The dominant-negative (DN) effect of mutant p53 on transactivation was universally observed after acute p53 activation.
• The cellular outcome of the DN effect was cell-type specific, and reducing mutant p53 levels abrogated this effect.
• Mutant p53's DN effect protected against radiation-induced death but did not enhance tumorigenesis.
• The R246S mutant did not promote tumorigenesis compared to p53(-/-) mice, irrespective of MDM2 presence, unlike the R172H mutant.

Conclusions:

• Mutant p53's dominant-negative (DN) property primarily influences acute responses.
• Gain-of-function (GOF) properties are mutation-type specific and not universally observed.
• The specific mutant form of p53 dictates its impact on cellular outcomes and tumorigenesis.